MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Siemens taps Harvard prof to replace interim health care CEO | Personnel Moves

Siemens taps Harvard prof to replace interim health care CEO | Personnel Moves

By

MassDevice.com Personnel Moves

Here are the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

  • Siemens taps Harvard prof to replace interim health care CEO
    Siemens AG’s (NYSE:SI) healthcare division tapped neuro-radiologist Dr. Gregory Sorenson to replace Randy Hall as CEO of Siemens Healthcare in the U.S. and Canada. Hall has acted as interim CEO since April 2010, when former CEO Michael Reitermann moved to a new role in the company’s diagnostics division. Sorenson, 49, is the co-director of the A.A. Martinos Center for Biomedical Imaging at Mass. General Hospital. The appointment is effective June 1.
    Read more

  • Comparative effectiveness institute names first director
    The controversial Patient-Centered Outcomes Research Institute named healthcare researcher Joe Selby as its first executive director. Selby is a health services researcher who has authored more than 200 peer-reviewed articles. He oversees a staff of more than 550 as director of division research at Kaiser Permanente. As a family physician, clinical epidemiologist, and health services researcher, Selby said he’d like to use his position at the institute to "make a difference in the lives of patients."

    Selby will identify opportunities and issues, and implement programs under the authority of PCORI’s board of governors. A key component of the Patient Protection & Affordable Care Act, the institute is an independent non-profit organization focused on comparative effectiveness research, which examines health outcomes and effectiveness of various medical treatments. The effort has met with much criticism from those who argue that comparative effectiveness research negatively affects patient options by giving preference to one-size-fits-all treatments that fail to consider unique patient circumstances.
    Read more

  • Foundation Medicine names new CEO
    Cambridge-based cancer diagnostics startup Foundation Medicine Inc. appointed former GE Healthcare head Michael Pellini as president and CEO. He replaces founding CEO Alexis Borisy, who will take the role of chairman of the board of directors.
    Read more

  • Welch Allyn president & CEO to join U.S. Commerce Innovation Advisory Board
    U.S. Secretary of Commerce Gary Locke named Julie Shimer, president and CEO of Welch Allyn and a member of the Advanced Medical Technology Assn.’s board, to an Innovation Advisory Board assigned to develop a study of America’s innovative capacity and global economic competitiveness. Over the weekend Shimer was also tapped by New York governor Andrew Cuomo to chair the Empire State Development Corp.
    Read more

  • University of the Sciences board of trustees elects two new members
    The USciences Board of Trustees elected Marvin Samson, CEO of Samson Medical Technologies, as chairman and Richard Howard, CEO of Advanced Pharmacy Services, as vice chairman. The election follows the recent retirement announcement of chairman Dr. Delbert Payne, who was subsequently elected emeritus trustee.
    Read more

  • Stem cell startup iPierian axes top execs
    San Francisco-based stem cell startup iPierian, with high-profile backers including GlaxoSmithKline, Kleiner Perkins Caufield & Byers, Google Ventures and Biogen Idec, terminated several members of the excutive team over the last month. The departures have not been publically announced, but roles have been updated on the company’s website.
    Read more

  • Abiomed board member steps down
    Desmond O’Connell Jr., an Abiomed (NSDQ:ABMD) board member since 1995, announced that he will not stand for reelection at the company’s 2011 stockholders’ meeting.
    Read more

  • Echo Therapeutics appoints new CFO
    Christopher Schnittker joined Echo Therapeutics Inc. (OTC:ECTE) as CFO, taking over from COO Harry Mitchell.
    Read more

  • Angeion announces new CFO and VP of engineering
    Angeion Corp. (NSDQ:ANGN) named Rob Wolf as CFO and Mark Gryzwa as vice president of engineering, effective today. Wolf and Gryzwa report to Angeion president and CEO Phil Smith.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Keep the end in mind when choosing a medtech partner
    There are five general categories of medtech vendor partners. If the end is apparent in the beginning, the correct type of partner will be more apparent. Jim Reed, Minnetronix Medical Stephen Covey gave the business world this mantra in one of his bestsellers: “Start with the end in mind.” Whether they didn’t read the book… […]
  • Orthofix launches Fiberfuse Strip bone graft
    Orthofix (NSDQ:OFIX) today announced that it has launched its FiberFuse Strip bone graft in the U.S. Lewisville, Texas–based Orthofix designed the FiberFuse Strip to be a preformed bone-graft strip for posterior cervical, posterior lumbar and degenerative spinal procedures. FiberFuse Strip is 100% bone and has a unique mixture of mineralized cancellous and demineralized cortical bone with… […]
  • Thermo Fisher Scientific beats The Street in Q2 results
    Thermo Fisher Scientific (NYSE:TMO) today posted second-quarter results that beat the overall consensus on Wall Street. The Waltham, Mass.–based company reported profits of $1.8 billion, or $4.61 per share, on sales of $9.3 billion for the three months ended July 1, 2021, for a bottom-line gain of 58.1% on sales growth of 34.1% compared with… […]
  • Choosing the Right Rubber Material and Process for Your Medical Parts
    When it’s time to design and develop a new medical device that calls for an elastomer component, there are a number of material options and manufacturing processes to consider. The long list of material properties impacting performance includes your prospective polymer’s end-use environment, chemical compatibility, hardness, compression set, tensile properties and manufacturability — to name… […]
  • 3M’s healthcare segment registers growth in Street-beating Q2
    3M (NYSE:MMM) reported second-quarter results that beat the consensus forecast — with the company’s healthcare segment showing especially robust growth. The St. Paul, Minn.–based company posted profits of $1.5 billion, or $2.59 per share, on sales of $9 billion for the three months ended June 30, 2021, for a 16.7% bottom-line gain on sales growth of… […]
  • Evren Technologies earbud PTSD treatment device nabs FDA breakthrough device designation
    Evren Technologies this week announced that it received FDA breakthrough device designation for its Phoenix earbud device that treats PTSD. Gainesville, Fla.-based Evren Technologies designed the Phoenix device as a discreet earbud design that delivers transcutaneous auricular vagal nerve stimulation in a closed-loop system. It can be paired with the company’s PTSD symptom tracking app… […]
  • BD acquires resorbable polymer maker Tepha
    BD (NYSE:BDX) today announced that it has acquired resorbable polymer technology maker Tepha for an undisclosed amount. Franklin Lakes, N.J.–based BD said that it will use Lexington, Mass.–based Tepha’s resorbable polymer technology to accelerate growth of the company’s surgical mesh for soft tissue repair, reconstruction and regeneration. Tepha’s GalaFlex portfolio is also included in the acquisition.… […]
  • LifeSignals remote patient monitor wins FDA clearance
    LifeSignals today announced that it has received FDA 510(k) clearance for its LX1550 multi-parameter remote monitoring platform. Fremont, Calif.–based LifeSignals designed the LX1550 to continuously collect patient physiological data from home and in healthcare settings. The platform has a single-use wearable multi-parameter biosensor that records electrocardiography (ECG), heart rate, respiration rate, skin temperature and body… […]
  • Blackrock Neurotech and ClearPoint Neuro want to automate brain implant surgeries
    ClearPoint Neuro (NSDQ:CLPT) announced an agreement with Blackrock Neurotech to develop automated technologies for brain implant surgeries. The partnership will seek to develop an automated surgical solution for implanting brain-computer interfaces (BCIs) into patients with neurological disorders — including from paralysis, ALS, blindness and hearing loss. Solana Beach, Calif.–based ClearPoint Neuro said in a news… […]
  • New Mountain Capital to acquire Flexan
    New Mountain Capital’s ILC Dover today announced that it has reached a definitive agreement to acquire Flexan for an undisclosed amount. Lincolnshire, Ill.–based Flexan is a contract design and manufacturing company specializing in high-precision silicone, rubber and thermoplastic components for the medical device industry. The acquisition will allow both companies to serve a broader client… […]
  • How COVID-19 changed medical device clinical trials forever
    The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on… […]

Leave a Reply